0.20
+0.029(+16.96%)
Currency In USD
| Previous Close | 0.18 |
| Open | 0.2 |
| Day High | 0.21 |
| Day Low | 0.2 |
| 52-Week High | 7.31 |
| 52-Week Low | 0.17 |
| Volume | 8,787 |
| Average Volume | 11,280 |
| Market Cap | 924,167 |
| PE | -0.09 |
| EPS | -2.26 |
| Moving Average 50 Days | 0.32 |
| Moving Average 200 Days | 1.14 |
| Change | 0.02 |
If you invested $1000 in Lipella Pharmaceuticals Inc. (LIPO) since IPO date, it would be worth $34.78 as of January 14, 2026 at a share price of $0.2. Whereas If you bought $1000 worth of Lipella Pharmaceuticals Inc. (LIPO) shares 3 years ago, it would be worth $8.04 as of January 14, 2026 at a share price of $0.2.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Lipella Pharmaceuticals Issues Letter from the CEO to Stockholders Following Nasdaq Delisting
GlobeNewswire Inc.
Jun 25, 2025 7:15 PM GMT
PITTSBURGH, June 25, 2025 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (OTC: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on developing therapies for diseases with significant unmet need, today issued a let
Lipella Pharmaceuticals Announces Delisting from Nasdaq Capital Market
GlobeNewswire Inc.
Jun 20, 2025 7:19 PM GMT
PITTSBURGH, June 20, 2025 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (OTC: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on developing therapies for diseases with significant unmet needs, today announced t
Lipella Pharmaceuticals Announces U.S. Patent Issuance for Diagnostic Technology
GlobeNewswire Inc.
Jun 17, 2025 12:30 PM GMT
PITTSBURGH, June 17, 2025 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on developing therapies for diseases with significant unmet need, today announced